Výsledky vyhledávání - "S F, Williams"

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

Publikováno v: Journal of Clinical Oncology. 15:1870-1879

PURPOSE To identify trends in high-dose therapy with autologous hematopoietic stem-cell support (autotransplants) for breast cancer (1989 to 1995). PATIENTS AND METHODS Analysis of patients who received autotransplants and were reported to the Autolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f382896e3ab3b6be4132285bb62ba296
https://doi.org/10.1200/jco.1997.15.5.1870

Zobrazit plný text záznamu

Neuropathology of the chronic epileptic syndrome induced by intrahippocampal tetanus toxin in rat: preservation of pyramidal cells and incidence of dark cells

Autor: S. F. Williams, B. J. Evans, S. A. Hughes, J. G. R. Jefferys

Publikováno v: Neuropathology and Applied Neurobiology. 18:53-70

A few nanograms of tetanus toxin injected into a rat hippocampus causes a chronic epileptic syndrome characterized by brief seizures that recur intermittently for about 6 weeks. Cognitive and other behavioural impairments persist after the seizures a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f23683c9fde4086d14373f535a1926
https://doi.org/10.1111/j.1365-2990.1992.tb00764.x

Zobrazit plný text záznamu

Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

Autor: J, Mehta, L I, Gordon, M S, Tallman, J N, Winter, A M, Evens, A O, Evens, O, Frankfurt, S F, Williams, D, Grinblatt, L, Kaminer, R, Meagher, S, Singhal

Publikováno v: Bone marrow transplantation. 38(2)

Sixty three patients aged 27-66 years (median 52) were allografted from HLA-matched sibling (n=47), 10 of 10 allele-matched unrelated (n=19), or one-antigen/allele-mismatched (n=7) donors aged 24-69 years (median 46) after a conditioning regimen comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36d0cd24c5c76fc605082727a7d07041
https://pubmed.ncbi.nlm.nih.gov/16751789

Zobrazit plný text záznamu

Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

Autor: S, Singhal, L I, Gordon, M S, Tallman, J N, Winter, A M, Evens, A O, Evens, O, Frankfurt, S F, Williams, D, Grinblatt, L, Kaminer, R, Meagher, J, Mehta

Publikováno v: Bone marrow transplantation. 37(6)

Whether the CD34+ and CD3+ cell doses in allogeneic HSCT should be estimated using actual (ABW) or ideal (IBW) body weight has never been definitively determined. We have shown that CD34+ cell doses based upon IBW are better predictive of engraftment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a26e89dcb427f02fd386f9efa6697348
https://pubmed.ncbi.nlm.nih.gov/16444282

Zobrazit plný text záznamu

Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?

Autor: M Y Ali, Y Oyama, J Monreal, J N Winter, M S Tallman, S F Williams, S Singhal, L I Gordon, J Mehta

Publikováno v: Bone marrow transplantation. 31(10)

The number of CD34+ cells infused influences the speed of hematologic recovery post-transplant. There are limited data on whether ideal (IBW) or actual (ABW) body weight should be used to calculate CD34+ cell dose. We compared the correlation between

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d401220f3a57ce0b60b8d90c6c62cd2c
https://pubmed.ncbi.nlm.nih.gov/12748662

Zobrazit plný text záznamu

Antineoplastic drugs administered during pregnancy

Autor: S F, Williams, R L, Schilsky

Publikováno v: Seminars in oncology. 27(6)

Cancer is the second leading cause of death in women during their reproductive years. Thus, antineoplastic drugs may be administered to pregnant women. The effects these agents have on the developing fetus depend on the type of agent and the timing o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e7a9dffaf308f47a840245dcd5e0142e
https://pubmed.ncbi.nlm.nih.gov/11130468

Zobrazit plný text záznamu

Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma

Autor: T M, Zimmerman, G C, Michelson, R, Mick, D L, Grinblatt, S F, Williams

Publikováno v: Journal of clinical apheresis. 14(1)

A subgroup of patients with refractory Hodgkin's (HD) or non-Hodgkin's (NHL) lymphoma may be cured with high-dose chemotherapy and peripheral blood progenitor cell rescue. To investigate the relationship of adequate leukapheresis yield and time cours

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::898595f0dd4e73701499d8887d69f0c4
https://pubmed.ncbi.nlm.nih.gov/10355661

Zobrazit plný text záznamu

A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients

Autor: E J, Shpall, C A, Wheeler, S A, Turner, S, Yanovich, R A, Brown, A L, Pecora, T C, Shea, K F, Mangan, S F, Williams, C F, LeMaistre, G D, Long, R, Jones, M W, Davis, R, Murphy-Filkins, W R, Parker, J A, Glaspy

Publikováno v: Blood. 93(8)

This randomized study compared the number of leukaphereses required to collect an optimal target yield of 5 x 10(6) CD34(+) peripheral blood progenitor cells/kg, using either stem cell factor (SCF) at 20 micrograms/kg/d in combination with Filgrastim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::093ff862d2f5a2b368e56aa7d6ab0323
https://pubmed.ncbi.nlm.nih.gov/10194427

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání